CDKV Holdings’s Abbott ABT Stock Holding History

CDKV Holdings’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26K	Hold	287	–	–	0.02%	167
2026 Q1	$29.4K	Sell	287 -450	-61%	-$50.8K	0.03%	152
2025 Q4	$92.3K	Buy	+737	New	+$93.9K	0.08%	107

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

CDKV Holdings's ABT Position: Q2 2026 in Review

CDKV Holdings held its Abbott (ABT) position steady in Q2 2026 at 287 shares worth $26K. The position accounts for 0.02% of the portfolio, ranked #167.

CDKV Holdings first reported a position in ABT in Q4 2025 and has held it in 3 quarters since. The position peaked at $92.3K in Q4 2025. 2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

CDKV Holdings held 287 shares of Abbott worth $26K as of Q2 2026.
CDKV Holdings left its Abbott share count unchanged in Q2 2026.
Abbott made up 0.02% of CDKV Holdings's portfolio in Q2 2026, its #167 holding.
CDKV Holdings first reported a position in Abbott in Q4 2025 and has held it in 3 quarters since.
CDKV Holdings's Abbott position peaked at $92.3K in Q4 2025.
2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on CDKV Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.